COVID-19 created challenges to diabetes care and accelerated the need to optimize healthcare delivery outside of traditional settings.
Due to stay-at-home orders, many clinicians sought remote patient monitoring (RPM) solutions to remain engaged with their patients with diabetes and to provide care.
This study examined RPM uptake and diabetes-related outcomes during the COVID-19 pandemic for more than 100,000 people with diabetes using Glooko’s RPM platform. The Glooko platform offered an important clinical tool to healthcare providers and patients during the pandemic, which resulted in increased engagement, improved glucose trends and increased self-monitoring.
Download to view the key findings.
DOWNLOAD